Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.12.24 | City View Green Holdings Inc: City View closes $234,750 first tranche of financing | 2 | Stockwatch | ||
23.12.24 | City View Green Holdings Inc.: City View Green Announces First Tranche Closing and Extension of Its Non-Brokered Private Placement | 279 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 23, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
27.11.24 | City View Green Holdings Inc: City View Green issues 78.08 million shares for debt | 1 | Stockwatch | ||
27.11.24 | City View Green Holdings Inc. Completes Issuance of Shares in Settlement of Debt | 207 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 27, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
06.11.24 | City View Green Holdings Inc. Announces Completion of Strategic Review and Debt Settlements | 285 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 6, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
18.10.24 | Canadian Cannabis Edibles Producer City View Green To Raise $730K Via Private Placement | 2 | Benzinga.com | ||
CITY VIEW GREEN Aktie jetzt für 0€ handeln | |||||
17.10.24 | City View Green Holdings Inc: City View Green arranges $1-million private placement | 1 | Stockwatch | ||
17.10.24 | City View Green Holdings Inc.: City View Announces Private Placement of up to $1,000,000 and Enters into IR Agreement | 191 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 17, 2024) - City View Green Holdings Inc. (CSE: CVGR) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles manufacturing... ► Artikel lesen | |
21.06.24 | City View Green Holdings Inc.: City View Green Announces First Tranche Closing and Extension of its Non-Brokered Private Placement | 579 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 20, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
06.05.24 | City View Green Holdings Inc.: City View Extends Private Placement of up to $1,000,000 | 536 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 6, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
17.04.24 | City View Green Holdings Inc. Exits Retail Cannabis Through Ownership in Budd Hutt & Announces Director Resignation | 499 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
04.03.24 | City View Green Holdings Inc.: City View Announces Private Placement of Up To $1,000,000 | 601 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 4, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 20,985 | -2,12 % | Bayer AKTIE | Analyse und Einschätzung für Investoren | ||
PFIZER | 25,235 | -1,25 % | Pfizer Aktie: Was Analysten zu berichten haben | Die US-amerikanische Pharmafirma Pfizer steht aktuell vor wichtigen strategischen Veränderungen. Der Konzern plant bedeutende Verkaufsaktivitäten, während die Aktie am letzten Handelstag bei 26,31 USD... ► Artikel lesen | |
SANOFI | 98,87 | -0,32 % | Aktie von Sanofi SA heute am Aktienmarkt gefragt (98,92 €) | Am Aktienmarkt liegt die Aktie von Sanofi SA zur Stunde im Plus. Das Wertpapier notiert aktuell bei 98,92 Euro. Ein Kursgewinn in Höhe von 75 Cent erfreut derzeit die Aktionäre von Sanofi SA. Die Aktie... ► Artikel lesen | |
INNOCAN PHARMA | 0,115 | -4,17 % | Innocan Pharma Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
DERMAPHARM | 40,500 | +0,25 % | Dermapharm: Aktie wird abgestuft | 2024 ist für Dermapharm gut verlaufen. Die Analysten von mwb research gehen davon aus, dass die Gesellschaft ihre Jahresprognose schaffen wird. Dermapharm rechnet mit einem Umsatz von 1,17 Milliarden... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
BAUSCH HEALTH | 7,320 | +2,18 % | Bausch Health Companies Inc.: Bausch Health Statement on Selection of XIFAXAN (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program | LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers for... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,112 | 0,00 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
SINOPHARM | 2,490 | -1,35 % | Sinopharm unit faces huge fall in profit | ||
INDIVA | 0,016 | -100,00 % | SNDL Inc.: SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition | CALGARY, AB, Nov. 4, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together... ► Artikel lesen | |
CSPC PHARMA | 0,530 | -2,00 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - REGORAFENIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL | ||
ORAMED PHARMACEUTICALS | 2,185 | -1,27 % | ORAMED PHARMACEUTICALS INC. - 8-K, Current Report | ||
ADASTRA | 0,194 | 0,00 % | Adastra Holdings Ltd.: Adastra Holdings Confirms Current Management | Langley, British Columbia--(Newsfile Corp. - January 20, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
CATALYST PHARMACEUTICALS | 22,060 | +0,23 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE in Japan | CORAL GABLES, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule amends, settles, converts debentures |